After this verification step, the PCR-SERS protocol was then applied to detect the methylation levels of p16, MGMT, and RASSF1 in actual plasma samples taken from 48 non-small-cell lung cancer (NSCLC) patients and 51 controls. This evidence concerns the gene MGMT and non-small cell lung carcinoma.